Click For Photo: http://static-13.sinclairstoryline.com/resources/media/0235dc50-a03e-4deb-8c60-fef125a2f2cc-large16x9_1280x720_81017P00KCLXZ.jpg?1545325593450
NEW YORK (AP) - The maker of Budweiser is partnering with medical cannabis company Tilray in a $100 million deal to research cannabis-infused drinks for the Canadian market.
The alliance announced Wednesday is the latest foray by a major beer company into the cannabis business in Canada, which legalized recreational marijuana in October.
Anheuser-Busch - InBev - Tilray - Inc - Project
Anheuser-Busch InBev and Tilray Inc. said each would invest $50 million in the project to study non-alcoholic drinks containing cannabidiol, or CBD, which some claim has calming and healing affects, and THC, the cannabis compound known for its psychoactive effects.
Belgium-based AB InBev, the owner of more than 500 beer brands including Budweiser and Stella Artois, said it will participate in the project through its subsidiary Labatt Breweries of Canada.
Labatt - Consumer - Trends - Labatt - Breweries
"Labatt is committed to staying ahead of emerging consumer trends," said Labatt Breweries President Kyle Norrington.
British Columbia-based Tilray has products available in 12 countries and operations in Australia, New Zealand, Canada, Germany, Latin America and Portugal.
Tilray - Shares - Percent - After-hours
Tilray's shares jumped 15 percent to after-hours...
(Excerpt) Read more at: KEYE
Wake Up To Breaking News!
Keep the change!